(Q36259724)
Statements
Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin (English)
Larisa L Belyanskaya
Thomas M Marti
Sally Hopkins-Donaldson
Stefanie Kurtz
Rolf A Stahel
22 October 2007
1 reference
1 reference
1 reference
1 reference